Latest news with #Rouen
Finextra
18 hours ago
- Business
- Finextra
Lemonway acquires PayGreen
Lemonway, the pan-European payment institution dedicated to marketplaces and crowdfunding platforms, announces the acquisition of PayGreen's business, a French specialist in e-commerce payments. 0 Founded in 2016, PayGreen has established itself in the restaurant, tourism, and leisure sectors. The Rouen-based company offers payment solutions including meal vouchers and holiday cheques, as well as tools for calculating the carbon emissions of online orders and a 'round-up' system that allows each transaction to support charitable projects or offset carbon emissions. Synergies to Dominate the European Payment Market This acquisition enables Lemonway to extend its expertise to e-commerce sites, complementing its historically marketplace-focused offering and third-party account payment solutions. The team of 11 employees, including PayGreen's three co-founders, will now form Lemonway's e-commerce department. As a payment institution regulated by the ACPR, Lemonway will also become PayGreen's Payment Service Provider (PSP), opening the doors to the European market where Lemonway already serves over 400 platforms in about 20 countries. 'This acquisition fits perfectly with our trajectory and ambition to become a key payment player in Europe. PayGreen's e-commerce positioning is highly complementary to ours. The combination of the two businesses will greatly enhance our customer offering,' explains Antoine Orsini, CEO and founder of Lemonway. Immediate Financial Impact and Promising Prospects This transaction immediately brings Lemonway: • A transaction volume of 20 million, generating €726 million in payments since the company's creation, with an average basket of €36.3. • A business that is EBITDA break-even. A Sovereign Payment Player 'This acquisition by Lemonway is a tremendous opportunity for us to accelerate our development at the European level. It was essential for us to join a French player sharing our values to build together a sovereign European payment champion. Our clients will now benefit from a more robust infrastructure and complementary expertise, giving them access to a complete payment ecosystem,' says Etienne Beaugrand, CEO and co-founder of PayGreen. A vision shared by Damien Guermonprez, Executive Chairman of Lemonway: 'In a technology-driven sector, our real strength lies in our teams' commitment and the quality of our customer support. With PayGreen joining us, we strengthen our ability to offer tailored and close support, making Lemonway the trusted partner for e-merchants and marketplaces in Europe'.
FF News
18 hours ago
- Business
- FF News
Lemonway Acquires PayGreen's Business
Lemonway, the pan-European payment institution dedicated to marketplaces and crowdfunding platforms, announces the acquisition of PayGreen's business, a French specialist in e-commerce payments. Founded in 2016, PayGreen has established itself in the restaurant, tourism, and leisure sectors. The Rouen-based company offers payment solutions including meal vouchers and holiday cheques, as well as tools for calculating the carbon emissions of online orders and a 'round-up' system that allows each transaction to support charitable projects or offset carbon emissions. Synergies to Dominate the European Payment Market This acquisition enables Lemonway to extend its expertise to e-commerce sites, complementing its historically marketplace-focused offering and third-party account payment solutions. The team of 11 employees, including PayGreen's three co-founders, will now form Lemonway's e-commerce department. As a payment institution regulated by the ACPR, Lemonway will also become PayGreen's Payment Service Provider (PSP), opening the doors to the European market where Lemonway already serves over 400 platforms in about 20 countries. 'This acquisition fits perfectly with our trajectory and ambition to become a key payment player in Europe. PayGreen's e-commerce positioning is highly complementary to ours. The combination of the two businesses will greatly enhance our customer offering,' explains Antoine Orsini, CEO and founder of Lemonway. This transaction immediately brings Lemonway: A transaction volume of 20 million, generating €726 million in payments since the company's creation, with an average basket of €36.3. A business that is EBITDA break-even. A Sovereign Payment Player 'This acquisition by Lemonway is a tremendous opportunity for us to accelerate our development at the European level. It was essential for us to join a French player sharing our values to build together a sovereign European payment champion. Our clients will now benefit from a more robust infrastructure and complementary expertise, giving them access to a complete payment ecosystem,' , says Etienne Beaugrand, CEO and co-founder of PayGreen. A vision shared by Damien Guermonprez, Executive Chairman of Lemonway: 'In a technology-driven sector, our real strength lies in our teams' commitment and the quality of our customer support. With PayGreen joining us, we strengthen our ability to offer tailored and close support, making Lemonway the trusted partner for e-merchants and marketplaces in Europe'. As a reminder, Lemonway ranked first in the financial services sector in Les Echos' 2024 ranking, with an average revenue growth of +63% from 2020 to 2023. Companies In This Post Lemonway
Daily Mail
02-06-2025
- Entertainment
- Daily Mail
French tennis star Harriet Dart told to 'wear DEODORANT' finally breaks her silence after 'disrespectful' comments
French tennis player Lois Boisson has broken her silence on British star Harriet Dart's eyebrow-raising on-court comments that suggested that she 'needed deodorant' during their meeting earlier this year. The bizarre encounter took place in France at the Rouen Open in April when Dart was 6-0 down in the first set and part of the way through the second against the home favourite. Rather than focus on her game, Dart made a surprising request to the umpire which was picked up by the courtside microphones, calling for the official to intervene and 'tell her to wear deodorant' because 'she's smelling really bad'. The game continued without further incident, with Dart losing straight sets to the 22-year-old. The British No4 later apologised for the outburst, saying that she was full of regret for the 'heat-of-the-moment' comment. Boisson has largely kept silent on events in the weeks since, only poking fun as the controversy quickly went viral on social media by calling upon cosmetics brand Dove to offer her a sponsorship. The British No4 made the comment to the umpire during a change of ends in their meeting at the Rouen Open Commenters on social media had been quick to call for Dart to receive some kind of sanction for the statements, with one dubbing her 'so disrespectful' and others saying she should be 'suspended'. But gearing up to make her debut in the fourth round of the French Open, Boisson shared her true feelings about the encounter on Sunday. 'It was not difficult to deal with,' Boisson insisted. 'It was okay. It was nothing for me. 'She maybe made a mistake, then I joked about it, that's it.' Boisson admitted that she 'didn't hear' the comments during the match, and only learned about the dig 'two hours later'. The Frenchwoman remained adamant that the name-calling did not affect her, adding: 'It was nothing. Something is cool, you know? 'I take it with the coolest.' Boisson will hope that she maintains a similar froideur when she steps onto Roland-Garros' Court Philippe-Chatrier on Monday to face off with number-three seed Jessica Pegula. The Frenchwoman was handed a wild card at her home tournament, and has before made such a deep run at a Grand Slam. Boisson returns to the tour in 2025 after she was forcibly sidelined with an anterior cruciate ligament tear a week before last year's French Open. The 22-year-old is gearing up for a historic fourth-round French Open tie with Jessica Pegula By contrast, Dart was knocked out of the singles tournament in the first round of qualifiers Then, she was ranked 152nd in the world, but after an extended spell out of the game, Boisson is now ranked in the high 300s. Regardless of her result against Pegula, however, Boisson is tracking to reach 170th at the world after her strong form in Paris saw her beat Elise Mertins, Anhelina Kalinina, and her compatriot Elsa Jacquemot. Dart meanwhile was unable to feature as a singles player on the red clay of Roland-Garros after her defeat in qualifiers in straight sets to Anastasiya Soboleva. The 28-year-old was later despatched in main draw doubles when she and Kimberly Birrell lost to Irina-Camelia Begu and Yanina Wickmayer in the first round.
Daily Mail
24-05-2025
- Health
- Daily Mail
Doctor issues urgent plea as sperm donor used to conceive 67 kids passes cancer-causing gene on to them - 10 now confirmed to have the disease
A doctor has issued an urgent plea after it was revealed a sperm donor used to conceive at least 67 children across Europe has passed on a rare cancer-causing mutation. Around 23 of those conceived from the donor's sperm between 2008 and 2015 have been found to carry a variant in the TP53 gene which provides instructions for making tumour proteins. And 10 of these children have already been diagnosed with cancers such as leukaemia and non-Hodgkin lymphoma. The case was described by Dr Edwige Kasper, a biologist at Rouen University Hospital in France, as an 'abnormal dissemination of genetic disease'. She urged The Guardian: 'We need to have a European limit on the number of births or families for a single donor. 'We can't do whole-genome sequencing for all sperm donors – I'm not arguing for that,' she added. 'But this is the abnormal dissemination of genetic disease. Not every man has 75 children across Europe.' The shocking revelation came to light when two separate families contacted their fertility clinics after their children were diagnosed with cancers connected to the a variant in the TP53 gene. Analysis by the European Sperm Bank which supplied the sperm confirmed that the rare variant was present in some of the donor's sperm. But they emphasised that it was not known to be linked to cancer at the time the sperm was donated in 2008 and it would not have been detected using standard screening techniques. Furthermore, the donor is thought to be in good health. The European Sperm Bank said that more than 67 children had been conceived using the donor's sperm, but that its policy does not allow them to confirm exact numbers of children for a specific donor. It said all of the relevant clinics had been alerted. Julie Paulli Budtz, a spokesperson for the European Sperm Bank, said: 'We are deeply affected by this case.' Although the donor had been thoroughly tested, she said that 'it is scientifically simply not possible to detect disease-causing mutations in a person's gene pool if you don't know what you are looking for'. She added: 'We welcome continued dialogue on setting an internationally mandated family limit, and have advocated for this on several occasions. 'This is also why we have proactively implemented our own international limit of 75 families per donor.' It is suggested that children who have the mutated TP53 gene undergo whole body and brain MRI scans. They are also advised to have regular breast and abdomen ultrasounds throughout adulthood. The case has sparked questions about the challenge of tracing the families affected and the lack of internationally agreed limits surrounding the use of a single sperm donor. Many European countries have their own limits on either the number of families that can use a donor or the number of children that can be conceived using the same donor. Current UK law allows for sperm from a single donor to be used to create a maximum of 10 families.
The Independent
24-05-2025
- Health
- The Independent
Sperm donor with cancer-causing gene passes on disease to 10 children
A sperm donor who has been used to conceive at least 67 children across Europe had a rare cancer -causing mutation, with 10 of the children developing the disease. Twenty-three of the children, conceived between 2008 and 2015 across eight countries, have now been found to carry the variant, while some have been diagnosed with cancers such as leukaemia and non-Hodgkin lymphoma. The case has raised concerns about the lack of internationally agreed limits on the use of a single sperm donor, and the difficulty in tracing a large number of families to inform them of a serious medical issue. The news was uncovered after two separate families contacted their fertility clinics becaues their children had developed cancers that were linked to a genetic variant called TP53. An analysis by the European Sperm Bank, who supplied the sperm, confirmed that the variant was present but was not known to be linked to cancer at the time of donation in 2008. Dr Edwige Kasper, a biologist at Rouen university hospital in France, said: 'We need to have a European limit on the number of births or families for a single donor. 'We can't do whole-genome sequencing for all sperm donors – I'm not arguing for that,' she added. 'But this is the abnormal dissemination of genetic disease. Not every man has 75 children across Europe.' She continued: 'I analysed the variant using population and patient databases, computer prediction tools and the results of functional trials and came to the conclusion that the variant was probably cancer-causing and that children born from this donor should receive genetic counselling.' Children who have been shown to have the gene are advised to have whole body and brain MRI scans. They are also recommend to have breast and abdomen ultrasounds as adults. Julie Paulli Budtz, a spokesperson for the European Sperm Bank, told The Guardian: 'We are deeply affected by this case.' She said the donor had been thoroughly tested but that 'it is scientifically simply not possible to detect disease-causing mutations in a person's gene pool if you don't know what you are looking for'. She added: 'We welcome continued dialogue on setting an internationally mandated family limit and have advocated for this on several occasions. This is also why we have proactively implemented our own international limit of 75 families per donor.'
